PUBCHEM ID |
121494087
|
UNII |
B2B1VB7X21
|
Preferred Term |
HYDROXOCOBALAMIN HYDROCHLORIDE
|
CAS |
59461-30-2
|
INCHIKEY |
KEHNCSYXYMMUCO-FBTIOKFQSA-K
|
Download |
mol2, pdbqt
|
mol2 |
|
Smiles |
C[C@H](CNC(CC[C@](C)([C@@H](CC(N)=O)[C@H]1/N2)/C2=C(\C)/C([C@@H](CCC(N)=O)/C2(C)C)=N/C2=C\C([C@@H](CCC(N)=O)/[C@]2(C)CC(N)=O)=N/C2=C(/C)\C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O)=O)O[P@@](O)(O[C@H]([C@@H](CO)O[C@@H]1n2c(cc(C)c(C)c3)c3nc2)[C@H]1O)=O
|
Total Surface Area |
916,18
|
Relative PSA |
0,37603
|
TPSA |
469,83
|
cLogS |
-8,127
|
MW |
1272,45
|
cLogP |
-0,7022
|
H-Acceptors |
27
|
H-Donors |
11
|
Ro5 violations |
3
|
Druglikeness |
-27,872
|
DrugScore |
0,130046448250931
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB-
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability I |
Caco2-
|
Caco-2 Permeability II |
-0,1406
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor I |
Non-inhibitor
|
P-glycoprotein Inhibitor II |
Non-inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity I |
High FHMT
|
Fish Toxicity II |
1,2633
|
Tetrahymena Pyriformis Toxicity I |
High TPT
|
Tetrahymena Pyriformis Toxicity II |
0,5603
|
Tetrahymena Pyriformis Toxicity |
Low HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity |
2,686
|
Carcinogenicity (Three-class) |
Non-required
|